{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:37:59Z","timestamp":1793090279822,"version":"4.5.0"},"reference-count":305,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272746"],"award-info":[{"award-number":["82272746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007764","name":"Lanzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024-QN-146"],"award-info":[{"award-number":["2024-QN-146"]}],"id":[{"id":"10.13039\/501100007764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105516","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:39:52Z","timestamp":1786059592000},"page":"105516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Irradiation-based development of tumor vaccines: Mechanistic insights and translational exploration"],"prefix":"10.1016","volume":"227","author":[{"given":"Jiangwen","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyue","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7454","key":"10.1016\/j.critrevonc.2026.105516_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12306","article-title":"cGAS produces a 2\u2032-5\u2032-linked cyclic dinucleotide second messenger that activates STING","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","article-title":"Systematic review of case reports on the abscopal effect","volume":"40","author":"Abuodeh","year":"2016","journal-title":"Curr. Probl. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib3","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.968434","article-title":"Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy","volume":"3","author":"Adkins","year":"2014","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib4","article-title":"Update Prognostic Potency of Vascular Endothelial Growth Factor-A in the Acute Lymphoblastic Leukemia Landscape: A Meta-Analysis","volume":"8","author":"Aghaei","year":"2025","journal-title":"Cancer Rep (Hoboken)"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.61186\/ijbc.16.2.84","article-title":"Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review","volume":"16","author":"Aghapour","year":"2024","journal-title":"Iran. J. Blood Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf032","article-title":"A phase I\/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies","volume":"30","author":"Ahmed","year":"2025","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1667\/RR13849.1","article-title":"Immunobiology of radiotherapy: new paradigms","volume":"182","author":"Ahmed","year":"2014","journal-title":"Radiat. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/PPO.0000000000000675","article-title":"Diversity in Cancer Care: Current Challenges and Potential Solutions to Achieving Equity in Clinical Trial Participation","volume":"29","author":"Akimoto","year":"2023","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41420-024-02171-4","article-title":"Blockade of CD73 potentiates radiotherapy antitumor immunity and abscopal effects via STING pathway","volume":"10","author":"An","year":"2024","journal-title":"Cell. Death Discov."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00262-015-1717-1","article-title":"A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2\/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit","volume":"64","author":"Anastasopoulou","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jrr\/rrx005","article-title":"Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation","volume":"58","author":"Ando","year":"2017","journal-title":"J. Radiat. Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4\u2013dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"issue":"27","key":"10.1016\/j.critrevonc.2026.105516_bib13","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1073\/pnas.1600363113","article-title":"Tumor-associated fibroblasts predominantly come from local and not circulating precursors","volume":"113","author":"Arina","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib14","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.1502276","article-title":"Production of Proinflammatory Cytokines by Monocytes in Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells","volume":"196","author":"Arterbery","year":"2016","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib15","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1007\/s00277-025-06387-x","article-title":"\"Galectin-9: A double-edged sword in Acute Myeloid Leukemia\"","volume":"104","author":"Aval","year":"2025","journal-title":"Ann. Hematol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1008363601515","article-title":"Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients","volume":"11","author":"Baars","year":"2000","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib17","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/sj.bjc.6600254","article-title":"A phase II study of active specific immunotherapy and 5-FU\/Leucovorin as adjuvant therapy for stage III colon carcinoma","volume":"86","author":"Baars","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib18","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.7150\/jca.46316","article-title":"Carbon ion triggered immunogenic necroptosis of nasopharyngeal carcinoma cells involving necroptotic inhibitor BCL-x","volume":"12","author":"Bao","year":"2021","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbrc.2015.02.001","article-title":"Irradiated fibroblasts promote epithelial-mesenchymal transition and HDGF expression of esophageal squamous cell carcinoma","volume":"458","author":"Bao","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib20","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1021\/acsnano.0c03109","article-title":"Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery","volume":"14","author":"Barberio","year":"2020","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","article-title":"Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy","volume":"19","author":"Barkal","year":"2018","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib22","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1007\/s00262-023-03471-x","article-title":"NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model","volume":"72","author":"Barsoumian","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2568125","article-title":"Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma","volume":"2016","author":"Bauer","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2543614","article-title":"A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages","volume":"14","author":"Bever","year":"2025","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","volume":"18","author":"Blass","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib26","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer Journal Clinicians"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/2326-6066.CIR-17-0075","article-title":"Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non\u2013Small Cell Lung Cancer Patients","volume":"5","author":"Bruno","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ni.1601","article-title":"Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation","volume":"9","author":"Burgdorf","year":"2008","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40425-019-0552-x","article-title":"Multiple antigen-engineered DC vaccines with or without IFNalpha to promote antitumor immunity in melanoma","volume":"7","author":"Butterfield","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib30","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.4049\/jimmunol.1300057","article-title":"Bruton's tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin","volume":"190","author":"Byrne","year":"2013","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3348","article-title":"Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer","volume":"7","author":"Cachot","year":"2021","journal-title":"Sci. Adv."},{"issue":"16_","key":"10.1016\/j.critrevonc.2026.105516_bib32","article-title":"Impact of HLA matching on clinical outcomes in a phase 2 trial of Bria-IMT plus anti PD1 in advanced breast cancer","volume":"43","author":"Calfa","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib33","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.4049\/jimmunol.1700433","article-title":"Blocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells","volume":"200","author":"Carmenate","year":"2018","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/2326-6066.CIR-14-0052","article-title":"Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival","volume":"2","author":"Carson","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib35","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-4652(199903)178:3<275::AID-JCP1>3.0.CO;2-Q","article-title":"Immunocytochemical localization of latent transforming growth factor-beta1 activation by stimulated macrophages","volume":"178","author":"Chong","year":"1999","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41416-024-02898-y","article-title":"The abscopal effects of sonodynamic therapy in cancer","volume":"132","author":"Collins","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2217\/imt.15.113","article-title":"Algenpantucel-L immunotherapy in pancreatic adenocarcinoma","volume":"8","author":"Coveler","year":"2016","journal-title":"Immunotherapy"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/CJI.0b013e3182a80237","article-title":"Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinoma","volume":"36","author":"Creelan","year":"2013","journal-title":"J. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105516_bib41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"25","key":"10.1016\/j.critrevonc.2026.105516_bib42","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","article-title":"Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105516_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jes.2023.07.012","article-title":"Molybdenum and cadmium co-induce necroptosis through Th1\/Th2 imbalance-mediated endoplasmic reticulum stress in duck ovaries","volume":"142","author":"Cui","year":"2024","journal-title":"J. Environ. Sci. (China)"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/path.6031","article-title":"CXCL16 inhibits epithelial regeneration and promotes fibrosis during the progression of radiation enteritis","volume":"259","author":"Cui","year":"2023","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105516_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.615240","article-title":"Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments","volume":"11","author":"Cuzzubbo","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib47","first-page":"432","article-title":"Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1","volume":"38","author":"D'Alterio","year":"2019","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41525-021-00200-0","article-title":"Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy","volume":"6","author":"Dai","year":"2021","journal-title":"NPJ Genom. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib49","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00262-022-03253-x","article-title":"Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study","volume":"72","author":"De Jaeghere","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105516_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-319-56017-5_2","article-title":"Ultraviolet Light Induced Generation of Reactive Oxygen Species","volume":"996","author":"de Jager","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-8-360","article-title":"The use of gamma-irradiation and ultraviolet-irradiation in the preparation of human melanoma cells for use in autologous whole-cell vaccines","volume":"8","author":"Deacon","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105516_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216898","article-title":"Irradiated tumour cell-derived microparticles upregulate MHC-I expression in cancer cells via DNA double-strand break repair pathway","volume":"592","author":"Deng","year":"2024","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105516_bib54","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti\u2013CTLA-4 Antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105516_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1040-8428(01)00110-X","article-title":"Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma","volume":"39","author":"Dillman","year":"2001","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00002371-200307000-00009","article-title":"Interferon-gamma or granulocyte-macrophage colony-stimulating factor administered as adjuvants with a vaccine of irradiated autologous tumor cells from short-term cell line cultures: a randomized phase 2 trial of the cancer biotherapy research group","volume":"26","author":"Dillman","year":"2003","journal-title":"J. Immunother."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib57","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib58","first-page":"473","article-title":"Changes in regulatory T cells of lung cancer patients before and after GM-CSF modified tumor cell vaccine treatment and their clinical significance","volume":"18","author":"Du","year":"2011","journal-title":"Chin. J. Cancer Biotheray"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib59","first-page":"285","article-title":"Sequential administration of GM-CSF (Sargramostim) and IL-2 +\/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial","volume":"23","author":"Elias","year":"2008","journal-title":"Cancer Biother Radiopharm."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.1978.77","article-title":"Immunological monitoring in a controlled trial of immunotherapy in stage IIB malignant melanoma","volume":"37","author":"Embleton","year":"1978","journal-title":"Br. J. Cancer"},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105516_bib61","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1158\/1078-0432.CCR-09-1540","article-title":"Effect of granulocyte\/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine","volume":"15","author":"Faries","year":"2009","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105516_bib62","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1245\/s10434-017-6072-3","article-title":"Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases","volume":"24","author":"Faries","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012717","article-title":"Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study","volume":"13","author":"Ferdinandus","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105516_bib64","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/1078-0432.CCR-14-2824","article-title":"Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions","volume":"21","author":"Filatenkov","year":"2015","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib65","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.1910856117","article-title":"CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas","volume":"117","author":"Flores-Toro","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/641c3e73-ee2c-4873-8896-1b3a2edc557b","article-title":"Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients","volume":"7","author":"Fong","year":"2012","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib67","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2012.06.020","article-title":"Radiation Therapy to Convert the Tumor Into an In Situ Vaccine","volume":"84","author":"Formenti","year":"2012","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105516_bib68","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1158\/1078-0432.CCR-17-3322","article-title":"Focal Irradiation and Systemic TGFbeta Blockade in Metastatic Breast Cancer","volume":"24","author":"Formenti","year":"2018","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib69","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib70","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41590-024-01804-1","article-title":"JAK-STAT signaling maintains homeostasis in T cells and macrophages","volume":"25","author":"Fortelny","year":"2024","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib71","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/1097-0142(197711)40:5<2091::AID-CNCR2820400517>3.0.CO;2-H","article-title":"A phase II study of autologous irradiated tumor cells plus BCG in patients with metastatic malignant melanoma","volume":"40","author":"Frederick Laucius","year":"1977","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.it.2012.10.004","article-title":"Type I interferon response and innate immune sensing of cancer","volume":"34","author":"Fuertes","year":"2013","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104587","article-title":"ATP and its metabolite adenosine cooperatively upregulate the antigen-presenting molecules on dendritic cells leading to IFN-gamma production by T cells","volume":"299","author":"Furuta","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib74","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105516_bib75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2018.04.030","article-title":"Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy","volume":"282","author":"Gao","year":"2018","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib76","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cell.2013.04.046","article-title":"Cyclic [G(2\u2032,5\u2032)pA(3\u2032,5\u2032)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase","volume":"153","author":"Gao","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib77","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1186\/s12885-025-14542-w","article-title":"Immunotherapy combined with radiotherapy in the treatment of lung cancer: a meta-analysis of therapeutic effectiveness, safety considerations, and abscopal effect","volume":"25","author":"Gao","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105516_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114673","article-title":"mtDNA\/RNA boosts radiation-induced abscopal effect via M1 macrophage polarization-promoted IFN-beta-dependent inflammatory response","volume":"155","author":"Gao","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib79","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4161\/hv.19795","article-title":"Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer","volume":"8","author":"Gardner","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105516_bib80","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1158\/0008-5472.CAN-04-1525","article-title":"Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes","volume":"64","author":"Garnett","year":"2004","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib81","first-page":"1076","article-title":"Myeloid-derived suppressor cells in predicting the efficacy and prognosis of PD-1 inhibitor combined with chemotherapy in non-small cell lung cancer patients","volume":"30","author":"Geng","year":"2025","journal-title":"Chin. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105516_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108737","article-title":"Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model","volume":"108","author":"Ghaffari-Nazari","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib83","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105516_bib84","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ejca.2015.07.035","article-title":"A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer","volume":"51","author":"Giaccone","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib85","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jso.2930310407","article-title":"Adjuvant chemo-immunotherapy in stage II carcinoma of the breast","volume":"31","author":"Giuliano","year":"1986","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib86","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-01962-2","article-title":"Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation","volume":"40","author":"Goedegebuure","year":"2021","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105516_bib87","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1470-2045(15)00054-6","article-title":"Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial","volume":"16","author":"Golden","year":"2015","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/2326-6066.CIR-13-0115","article-title":"An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer","volume":"1","author":"Golden","year":"2013","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105516_bib89","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28518","article-title":"Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death","volume":"3","author":"Golden","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105516_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/srep46714","article-title":"Ionizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts","volume":"7","author":"Grinde","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1073\/pnas.85.1.185","article-title":"Base substitutions, frameshifts, and small deletions constitute ionizing radiation-induced point mutations in mammalian cells","volume":"85","author":"Grosovsky","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib92","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s43018-025-01058-2","article-title":"Cryoablation plus sintilimab and lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial","volume":"7","author":"Gu","year":"2026","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41551-021-00795-w","article-title":"Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns","volume":"6","author":"Guo","year":"2022","journal-title":"Nat. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib94","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.it.2017.04.002","article-title":"Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo","volume":"38","author":"Halle","year":"2017","journal-title":"Trends Immunol."},{"issue":"17-19","key":"10.1016\/j.critrevonc.2026.105516_bib95","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/S0264-410X(00)00485-0","article-title":"Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise","volume":"19","author":"Hanna","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib96","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/1097-0142(19910501)67:9<2269::AID-CNCR2820670910>3.0.CO;2-Z","article-title":"Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells","volume":"67","author":"Hareyama","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib97","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1200\/JCO.2000.18.1.148","article-title":"Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283","volume":"18","author":"Harris","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib98","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2020.09.041","article-title":"Reduction of Lung Metastases in a Mouse Osteosarcoma Model Treated With Carbon Ions and Immune Checkpoint Inhibitors","volume":"109","author":"Helm","year":"2021","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib99","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"237","key":"10.1016\/j.critrevonc.2026.105516_bib100","doi-asserted-by":"crossref","first-page":"237ra267","DOI":"10.1126\/scitranslmed.3007974","article-title":"Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy","volume":"6","author":"Highfill","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105516_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-019-0103-y","article-title":"Turning the corner on therapeutic cancer vaccines","volume":"4","author":"Hollingsworth","year":"2019","journal-title":"NPJ Vaccin."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib102","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40259-024-00669-y","article-title":"Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors","volume":"38","author":"Holtermann","year":"2024","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib103","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.1993.11.3.390","article-title":"Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial","volume":"11","author":"Hoover","year":"1993","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib104","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ssu.2980050610","article-title":"Active immunotherapy in colorectal cancer","volume":"5","author":"Hoover","year":"1989","journal-title":"Semin. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib105","first-page":"1671","article-title":"Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guerin vaccine","volume":"44","author":"Hoover","year":"1984","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib106","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/SLA.0b013e3182380f56","article-title":"Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma","volume":"255","author":"Hoshimoto","year":"2012","journal-title":"Ann. Surg."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105516_bib107","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1200\/JCO.2002.01.151","article-title":"Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine","volume":"20","author":"Hsueh","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib108","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21882","article-title":"Genetically modified cancer vaccines: Current status and future prospects","volume":"42","author":"Hu","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib109","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib110","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s43018-025-01018-w","article-title":"Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer","volume":"6","author":"Huang","year":"2025","journal-title":"Nat. Cancer"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105516_bib111","doi-asserted-by":"crossref","first-page":"542","DOI":"10.21037\/atm.2019.09.128","article-title":"Comparison of the effects of photon, proton and carbon-ion radiation on the ecto-calreticulin exposure in various tumor cell lines","volume":"7","author":"Huang","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib112","article-title":"Two-dimensional coordination risedronate-manganese nanobelts as adjuvant for cancer radiotherapy and immunotherapy","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105516_bib113","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/onco.13767","article-title":"Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials","volume":"26","author":"Huey","year":"2021","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib114","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.1890512","article-title":"Intratumoral therapies and in-situ vaccination for melanoma","volume":"18","author":"Huppert","year":"2022","journal-title":"Human. Vaccin. & Immunother."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105516_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111671","article-title":"Necessities in the Processing of DNA Double Strand Breaks and Their Effects on Genomic Instability and Cancer","volume":"11","author":"Iliakis","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib116","article-title":"Updates on HPV Vaccination","volume":"13","author":"Illah","year":"2023","journal-title":"Diagn. (Basel)"},{"issue":"7265","key":"10.1016\/j.critrevonc.2026.105516_bib117","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib118","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1074-7613(03)00175-4","article-title":"Distinct Dendritic Cell Populations Sequentially Present Antigen to CD4 T Cells and Stimulate Different Aspects of Cell-Mediated Immunity","volume":"19","author":"Itano","year":"2003","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105516_bib119","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-17-3179","article-title":"FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia","volume":"24","author":"Jen","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105516_bib120","article-title":"Radiotherapy-Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth","volume":"11","author":"Ji","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.critrevonc.2026.105516_bib121","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.redox.2018.09.007","article-title":"Curcumol induces RIPK1\/RIPK3 complex-dependent necroptosis via JNK1\/2-ROS signaling in hepatic stellate cells","volume":"19","author":"Jia","year":"2018","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib122","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1163462","article-title":"Role of IL-2 in cancer immunotherapy","volume":"5","author":"Jiang","year":"2016","journal-title":"Oncoimmunology"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105516_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/cells12172159","article-title":"Cancer Vaccine Therapeutics: Limitations and Effectiveness\u2014A Literature Review","volume":"12","author":"Kaczmarek","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib124","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/j.1349-7006.2008.00978.x","article-title":"Irradiated fibroblast-induced bystander effects on invasive growth of squamous cell carcinoma under cancer-stromal cell interaction","volume":"99","author":"Kamochi","year":"2008","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11864-025-01295-8","article-title":"Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma","volume":"26","author":"Karimi","year":"2025","journal-title":"Curr. Treat. Options Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib126","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.seminoncol.2012.02.007","article-title":"Whole Cell Vaccines\u2014Past Progress and Future Strategies","volume":"39","author":"Keenan","year":"2012","journal-title":"Semin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib127","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846935","article-title":"Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches","volume":"19","author":"Khoo","year":"2018","journal-title":"EMBO Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib128","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4143\/crt.2023.502","article-title":"Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105516_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110480","article-title":"vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model","volume":"200","author":"Kim","year":"2024","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood-2011-05-355222","article-title":"situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1\/2 study","volume":"119","author":"Kim","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib131","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2013-09-512749","article-title":"Oxidative stress in angiogenesis and vascular disease","volume":"123","author":"Kim","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib132","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00184874","article-title":"Adjuvant treatment of locally advanced renal cancer with autologous virus-modified tumor vaccines","volume":"13","author":"Kirchner","year":"1995","journal-title":"World J. Urol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib133","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00262-019-02320-0","article-title":"Autologous tumor cell vaccination combined with systemic CpG-B and IFN-alpha promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial","volume":"68","author":"Koster","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib134","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic Cell Death in Cancer Therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105516_bib135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib136","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011487","article-title":"Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effect","volume":"13","author":"Laurent","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib137","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1200\/JCO.2014.57.4244","article-title":"Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer","volume":"33","author":"Le","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib138","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01771453","article-title":"Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine","volume":"32","author":"Lehner","year":"1990","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105516_bib139","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejca.2016.09.013","article-title":"Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1\/2 trial","volume":"68","author":"Levy","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib140","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0721-x","article-title":"Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy","volume":"12","author":"Li","year":"2019","journal-title":"J. Hematol. & Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib141","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib142","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.vaccine.2008.11.014","article-title":"Whole tumor cell vaccine with irradiated S180 cells as adjuvant","volume":"27","author":"Li","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.critrevonc.2026.105516_bib143","doi-asserted-by":"crossref","first-page":"xii11","DOI":"10.1093\/annonc\/mdx681","article-title":"Preclinical and clinical development of neoantigen vaccines","volume":"28","author":"Li","year":"2017","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib144","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.imlet.2007.07.019","article-title":"Synergistic antitumor effect of chemotactic-prostate tumor-associated antigen gene-modified tumor cell vaccine and anti-CTLA-4 mAb in murine tumor model","volume":"113","author":"Li","year":"2007","journal-title":"Immunol. Lett."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib145","first-page":"2192","article-title":"Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblasts","volume":"6","author":"Li","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105516_bib146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molimm.2018.02.014","article-title":"HMGB1 regulates T helper 2 and T helper17 cell differentiation both directly and indirectly in asthmatic mice","volume":"97","author":"Li","year":"2018","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.46","article-title":"Conditions for the generation of cytotoxic CD4(+) Th cells that enhance CD8(+) CTL-mediated tumor regression","volume":"5","author":"Li","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105516_bib148","article-title":"Fragment Autoantigens Stimulated T-Cell-Immunotherapy (FAST) as a Fast Autologous Cancer Vaccine","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib149","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12929-024-01102-w","article-title":"Advances in nucleic acid-based cancer vaccines","volume":"32","author":"Liao","year":"2025","journal-title":"J. Biomed. Sci."},{"issue":"9_","key":"10.1016\/j.critrevonc.2026.105516_bib150","first-page":"V55","article-title":"The therapeutic misconception: problems and solutions","volume":"40","author":"Lidz","year":"2002","journal-title":"Med. Care"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib151","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105516_bib152","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.7150\/thno.43539","article-title":"Radiation-induced small extracellular vesicles as \"carriages\" promote tumor antigen release and trigger antitumor immunity","volume":"10","author":"Lin","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib153","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12094-024-03587-1","article-title":"Clinicopathologic and prognostic significance of tumor-associated macrophages in cervical cancer: a systematic review and meta-analysis","volume":"27","author":"Lin","year":"2025","journal-title":"Clin. Transl. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105516_bib154","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1021\/acsbiomaterials.3c01154","article-title":"Advances in Cancer Vaccine Research","volume":"9","author":"Liu","year":"2023","journal-title":"ACS Biomater. Sci. & Eng."},{"issue":"6227","key":"10.1016\/j.critrevonc.2026.105516_bib155","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib156","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. & Oncol."},{"issue":"33","key":"10.1016\/j.critrevonc.2026.105516_bib157","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1016\/j.biomaterials.2013.07.020","article-title":"Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib158","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0647-8","article-title":"Abscopal effect of radiotherapy combined with immune checkpoint inhibitors","volume":"11","author":"Liu","year":"2018","journal-title":"J. Hematol. & Oncol."},{"key":"10.1016\/j.critrevonc.2026.105516_bib159","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.actbio.2022.03.023","article-title":"Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer","volume":"144","author":"Liu","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.critrevonc.2026.105516_bib160","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8121985","article-title":"Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade","volume":"2016","author":"Lotem","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib161","first-page":"S21","article-title":"Improving Racial and Ethnic Equity in Clinical Trials Enrolling Pregnant and Lactating Individuals","volume":"63","author":"Louis-Jacques","year":"2023","journal-title":"J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/biom12091167","article-title":"Deciphering the Biological Effects of Radiotherapy in Cancer Cells","volume":"12","author":"Lu","year":"2022","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib163","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.180.5.3132","article-title":"Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity","volume":"180","author":"Lugade","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105516_bib164","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.2147\/OTT.S197516","article-title":"Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo","volume":"12","author":"Luo","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105516_bib165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102611118","article-title":"Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads","volume":"118","author":"Lussier","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib166","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/SLA.0b013e3181fd271c","article-title":"A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation","volume":"253","author":"Lutz","year":"2011","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib167","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00169-11","article-title":"Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection","volume":"2","author":"Mack","year":"2011","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib168","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1517\/13543784.2012.684753","article-title":"Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection","volume":"21","author":"Mackiewicz","year":"2012","journal-title":"Expert. Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib169","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1863631","article-title":"A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes","volume":"10","author":"Maity","year":"2021","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105516_bib170","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-023-05792-5","article-title":"Research progress on tumor whole-cell vaccines prepared with nanoparticles for tumor immunotherapy","volume":"25","author":"Mao","year":"2023","journal-title":"J. Nanopart. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib171","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2021.09.016","article-title":"Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study","volume":"81","author":"Masini","year":"2022","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib172","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1667\/RR1860.1","article-title":"Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation","volume":"173","author":"Matsumura","year":"2010","journal-title":"Radiat. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib173","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.181.5.3099","article-title":"Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells","volume":"181","author":"Matsumura","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib174","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cllc.2021.01.012","article-title":"A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung Cancer","volume":"22","author":"Mattes","year":"2021","journal-title":"Clin. Lung Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1200\/JCO.20.00290","article-title":"Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma","volume":"39","author":"McBride","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib176","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105516_bib177","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJMcibr1501818","article-title":"Mutation-specific T cells for immunotherapy of gliomas","volume":"372","author":"Melief","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105516_bib178","series-title":"Eliminating Healthcare Disparities in America: Beyond the IOM Report","first-page":"21","article-title":"Epidemiology of Racial and Ethnic Disparities in Health and Healthcare","author":"Mensah","year":"2007"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib179","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib180","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4049\/jimmunol.2300326","article-title":"Dose-Specific Intratumoral GM-CSF Modulates Breast Tumor Oxygenation and Antitumor Immunity","volume":"211","author":"Mihalik","year":"2023","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020167","article-title":"IL-12 Family Cytokines in Cancer and Immunotherapy","volume":"13","author":"Mirlekar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105516_bib182","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2024-198942","article-title":"CCL8\/CCL13-Producing Tumor-Associated Macrophages Linked to Poor Outcomes after CAR T Cell Therapy for LBCL","volume":"144","author":"Mo","year":"2024","journal-title":"Blood"},{"issue":"305","key":"10.1016\/j.critrevonc.2026.105516_bib183","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole Body Irradiation? adiobiology or Medicine?*","volume":"26","author":"Mole","year":"1953","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.critrevonc.2026.105516_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1403771","article-title":"Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis","volume":"15","author":"Moller","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib185","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1395996","article-title":"PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation","volume":"7","author":"Morisada","year":"2018","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib186","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199210000-00010","article-title":"Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine","volume":"216","author":"Morton","year":"1992","journal-title":"Ann. Surg."},{"issue":"29","key":"10.1016\/j.critrevonc.2026.105516_bib187","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1200\/JCO.2005.05.5335","article-title":"Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer","volume":"24","author":"Nemunaitis","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib188","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/cgt.2009.15","article-title":"Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients","volume":"16","author":"Nemunaitis","year":"2009","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib189","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1038\/s41467-024-51807-7","article-title":"Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial","volume":"15","author":"Ni","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molcel.2019.02.013","article-title":"Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3","volume":"74","author":"Ning","year":"2019","journal-title":"Mol. Cell."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib191","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1634\/theoncologist.2019-0146","article-title":"Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention","volume":"24","author":"Nipp","year":"2019","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105516_bib192","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s43018-022-00456-0","article-title":"Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect","volume":"3","author":"Nishiga","year":"2022","journal-title":"Nat. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib193","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.194.6.781","article-title":"C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells","volume":"194","author":"Ogden","year":"2001","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib194","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ygyno.2016.09.018","article-title":"Phase II study of Vigil(R) DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer","volume":"143","author":"Oh","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib195","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1158\/0008-5472.CAN-03-2464","article-title":"Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions","volume":"64","author":"Ohuchida","year":"2004","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib196","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1073\/pnas.1820388116","article-title":"Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity","volume":"116","author":"Onda","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib197","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11122002","article-title":"JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression","volume":"11","author":"Owen","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib198","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1084\/jem.183.5.2209","article-title":"CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions","volume":"183","author":"Oxenius","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105516_bib199","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.801230","article-title":"Ionizing Radiation-Induced GDF15 Promotes Angiogenesis in Human Glioblastoma Models by Promoting VEGFA Expression Through p-MAPK1\/SP1 Signaling","volume":"12","author":"Park","year":"2022","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105516_bib200","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.4161\/hv.29418","article-title":"Peptide-based vaccines for cancer therapy","volume":"10","author":"Parmiani","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105516_bib201","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ncomms1524","article-title":"CD91-dependent programming of T-helper cell responses following heat shock protein immunization","volume":"2","author":"Pawaria","year":"2011","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib202","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib203","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: an emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105516_bib204","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/1742-2094-9-269","article-title":"Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis","volume":"9","author":"Phares","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"8072","key":"10.1016\/j.critrevonc.2026.105516_bib206","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-025-08994-0","article-title":"Radiation-induced amphiregulin drives tumour metastasis","volume":"643","author":"Piffko","year":"2025","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib207","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib208","doi-asserted-by":"crossref","first-page":"175","DOI":"10.14712\/fb2004050060175","article-title":"Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II","volume":"50","author":"Pizza","year":"2004","journal-title":"Folia Biol. (Praha)"},{"key":"10.1016\/j.critrevonc.2026.105516_bib209","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2020.01147","article-title":"Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF","volume":"11","author":"Podaza","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib210","first-page":"435","article-title":"Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway","volume":"89","author":"Porakishvili","year":"2004","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib211","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.lungcan.2006.01.007","article-title":"Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma","volume":"52","author":"Powell","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2026.105516_bib212","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jconrel.2023.05.044","article-title":"Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer","volume":"359","author":"Qin","year":"2023","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib213","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20091918","article-title":"Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts","volume":"207","author":"Quezada","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105516_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.666282","article-title":"Irradiation-Induced Changes in the Immunogenicity of Lung Cancer Cell Lines: Based on Comparison of X-rays and Carbon Ions","volume":"9","author":"Ran","year":"2021","journal-title":"Front. Public. Health"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib215","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20052494","article-title":"Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy","volume":"203","author":"Reits","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105516_bib216","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.974912","article-title":"Tumor cell-based vaccine contributes to local tumor irradiation by eliciting a tumor model-dependent systemic immune response","volume":"13","author":"Remic","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8010111","article-title":"Development of Tumor Cell-Based Vaccine with IL-12 Gene Electrotransfer as Adjuvant","volume":"8","author":"Remic","year":"2020","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib218","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib219","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical Role for CD103+\/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105516_bib220","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1655964","article-title":"Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients","volume":"8","author":"Rodriguez-Ruiz","year":"2019","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib221","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","article-title":"Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect","volume":"39","author":"Rodriguez-Ruiz","year":"2018","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib222","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1681\/ASN.2010040430","article-title":"Dangers within: DAMP responses to damage and cell death in kidney disease","volume":"22","author":"Rosin","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib223","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib224","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ccell.2020.05.002","article-title":"Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells","volume":"37","author":"Ruhland","year":"2020","journal-title":"Cancer Cell."},{"issue":"6382","key":"10.1016\/j.critrevonc.2026.105516_bib225","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib226","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1158\/2326-6066.CIR-14-0079","article-title":"Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91","volume":"3","author":"Salimu","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105516_bib227","article-title":"Cancer Vaccines: A Novel Revolutionized Approach to Cancer Therapy","author":"Sarangi","year":"2024","journal-title":"Indian. J. Clin. Biochem."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105516_bib228","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1338238","article-title":"Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer","volume":"6","author":"Sarhan","year":"2017","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105516_bib229","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01741145","article-title":"Active specific immunotherapy with Newcastle-diseasevirus-modified autologous tumor cells following resection of liver metastases in colorectal cancer","volume":"35","author":"Schlag","year":"1992","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib231","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0022-5347(05)67771-3","volume":"163","author":"Schwaab","year":"2000","journal-title":"J. Urol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib232","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: a matter of life and death","volume":"15","author":"Schwabe","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105516_bib233","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.884827","article-title":"IL-27 Improves Prophylactic Protection Provided by a Dead Tumor Cell Vaccine in a Mouse Melanoma Model","volume":"13","author":"Seaver","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib234","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/14760584.2019.1674144","article-title":"How vaccines work: immune effector mechanisms and designer vaccines","volume":"18","author":"Sell","year":"2019","journal-title":"Expert. Rev. Vaccin."},{"key":"10.1016\/j.critrevonc.2026.105516_bib235","doi-asserted-by":"crossref","unstructured":"Sharma, P., Allison, J.P.J.C., 2015. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. 161(2), 205-214. http:\/\/dx.doi.org\/10.1016\/j.cell.2015.03.030.","DOI":"10.1016\/j.cell.2015.03.030"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105516_bib236","article-title":"PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell Carcinoma","volume":"13","author":"Shen","year":"2026","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib237","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10238-025-01751-7","article-title":"Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective","volume":"25","author":"Sherafat","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib238","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.4049\/jimmunol.1101304","article-title":"Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells","volume":"188","author":"Shirota","year":"2012","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib239","first-page":"853","article-title":"Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine","volume":"3","author":"Souberbielle","year":"1996","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib240","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/bjc.1981.217","article-title":"Failure of specific active immunotherapy in lung cancer","volume":"44","author":"Souter","year":"1981","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib241","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4(+) T cells in cancer","volume":"4","author":"Speiser","year":"2023","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib242","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.semradonc.2021.02.001","article-title":"Mechanisms of Immune Modulation by Radiation","volume":"31","author":"Spina","year":"2021","journal-title":"Semin. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib243","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","article-title":"Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine","volume":"70","author":"Srivastava","year":"2010","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105516_bib244","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201906832","article-title":"Codelivery of Anti-PD-1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual-Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy","volume":"16","author":"Su","year":"2020","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib245","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20220170","article-title":"A self-assembled, genetically engineered, irradiated tumor cell debris vaccine","volume":"4","author":"Sun","year":"2024","journal-title":"Exploration"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib246","article-title":"Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity","volume":"4","author":"Sun","year":"2023","journal-title":"Cell. Rep. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib247","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ijrobp.2019.03.041","article-title":"Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma","volume":"104","author":"Sundahl","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105516_bib248","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1395978","article-title":"Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanoma","volume":"14","author":"Sussman","year":"2024","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105516_bib249","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11071254","article-title":"Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model","volume":"11","author":"Szebeni","year":"2023","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13045-020-00985-0","article-title":"HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1\/2 pathway","volume":"13","author":"Tan","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib251","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191009","article-title":"Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells","volume":"217","author":"Tanaka","year":"2020","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib252","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-kappaB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib253","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib254","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12103022","article-title":"Carbon Ion Radiobiology","volume":"12","author":"Tinganelli","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib255","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/0008-5472.CAN-17-0524","article-title":"Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation","volume":"78","author":"Tommelein","year":"2018","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib256","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib257","doi-asserted-by":"crossref","first-page":"40","DOI":"10.32607\/actanaturae.11523","article-title":"Immunogenic Cell Death in Cancer Therapy","volume":"14","author":"Troitskaya","year":"2022","journal-title":"Acta Nat."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105516_bib258","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1158\/0008-5472.CAN-05-0703","article-title":"Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment","volume":"65","author":"Tsai","year":"2005","journal-title":"Cancer Res."},{"issue":"17-18","key":"10.1016\/j.critrevonc.2026.105516_bib259","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.vaccine.2005.01.015","article-title":"Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits","volume":"23","author":"Uyl-de Groot","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.critrevonc.2026.105516_bib260","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"issue":"9150","key":"10.1016\/j.critrevonc.2026.105516_bib261","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(98)07186-4","article-title":"Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial","volume":"353","author":"Vermorken","year":"1999","journal-title":"Lancet (Lond. Engl. )"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib262","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2013.06.013","article-title":"Ionizing-radiation induced DNA double-strand breaks: A direct and indirect lighting up","volume":"108","author":"Vignard","year":"2013","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib263","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1610-0387.2003.02014.x","article-title":"Intradermal injection of Newcastle disease virus-modified autologous melanoma cell lysate and interleukin-2 for adjuvant treatment of melanoma patients with resectable stage III disease","volume":"1","author":"Voit","year":"2003","journal-title":"J. Dtsch Dermatol. Ges."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105516_bib264","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and Challenges in the Delivery of mRNA-based Vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib265","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/em.2860050514","article-title":"Detection and repair of DNA base damages produced by ionizing radiation","volume":"5","author":"Wallace","year":"1983","journal-title":"Environ. Mutagen."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105516_bib266","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9789","article-title":"Irradiated tumor cell-derived microparticles mediate tumor eradication via cell killing and immune reprogramming","volume":"6","author":"Wan","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib267","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib268","article-title":"Biological effects of radiation on cancer cells","volume":"5","author":"Wang","year":"2018","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib269","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2018.01.036","article-title":"Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo","volume":"101","author":"Wang","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105516_bib270","doi-asserted-by":"crossref","first-page":"13278","DOI":"10.1021\/acsnano.3c00941","article-title":"Liquid Metal Nanoplatform Based Autologous Cancer Vaccines","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib271","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-020-00950-x","article-title":"HMGB1 in inflammation and cancer","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib272","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2022.12.029","article-title":"Cancer-Associated Fibroblasts Promote Radioresistance of Breast Cancer Cells via the HGF\/c-Met Signaling Pathway","volume":"116","author":"Wang","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib273","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-019-0362-2","article-title":"Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities","volume":"17","author":"Wang","year":"2019","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.critrevonc.2026.105516_bib274","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0079-6603(08)60611-X","article-title":"DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability","volume":"35","author":"Ward","year":"1988","journal-title":"Prog. Nucleic Acid. Res. Mol. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib275","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105516_bib276","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental Mechanisms of Immune Checkpoint Blockade Therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105516_bib277","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI81603","article-title":"CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer","volume":"126","author":"Weiskopf","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib278","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1158\/2326-6066.CIR-18-0793","article-title":"Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses","volume":"7","author":"Welsh","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib279","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/JCO.2015.63.2463","article-title":"Financial Concerns About Participation in Clinical Trials Among Patients With Cancer","volume":"34","author":"Wong","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib280","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105516_bib281","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1158\/1078-0432.CCR-20-1025","article-title":"A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer","volume":"26","author":"Wu","year":"2020","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib282","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105516_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102074","article-title":"Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8(+) T cells","volume":"48","author":"Xia","year":"2024","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib284","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.20091921","article-title":"Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma","volume":"207","author":"Xie","year":"2010","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105516_bib285","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.apsb.2024.02.015","article-title":"Radiation-based immunogenic vaccine combined with a macrophage \"checkpoint inhibitor\" for boosting innate and adaptive immunity against metastatic colon cancers","volume":"14","author":"Xu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib286","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12672-023-00682-7","article-title":"The abscopal effect of anti-CD95 and radiotherapy in melanoma","volume":"14","author":"Xu","year":"2023","journal-title":"Discov. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105516_bib287","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41590-020-0751-0","article-title":"Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Nat. Immunol."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105516_bib288","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111825","article-title":"The Dual Role of B Cells in the Tumor Microenvironment: Implications for Cancer Immunology and Therapy","volume":"25","author":"Yang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"41","key":"10.1016\/j.critrevonc.2026.105516_bib289","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf6290","article-title":"ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib290","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/cam4.2763","article-title":"A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer","volume":"9","author":"Yarchoan","year":"2020","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib291","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bph.12008","article-title":"Interleukins in glioblastoma pathophysiology: implications for therapy","volume":"168","author":"Yeung","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib292","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jrr\/rrv007","article-title":"Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation","volume":"56","author":"Yoshimoto","year":"2015","journal-title":"J. Radiat. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib293","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00262-024-03934-9","article-title":"Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-alpha1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial","volume":"74","author":"Yu","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib294","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jhep.2018.10.040","article-title":"Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma","volume":"70","author":"Yu","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib295","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105516_bib296","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41419-022-05444-x","article-title":"Endoplasmic reticulum stress-mediated cell death in liver injury","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell. death Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105516_bib297","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00262-017-2087-7","article-title":"Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model","volume":"67","author":"Zhang","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105516_bib298","article-title":"Neoantigen: A New Breakthrough in Tumor Immunotherapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105516_bib299","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109679","article-title":"Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial","volume":"184","author":"Zhao","year":"2023","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib300","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/s41467-025-60239-w","article-title":"A cowpea mosaic virus adjuvant conjugated to liposomes loaded with tumor cell lysates as an ovarian cancer vaccine","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105516_bib301","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.trsl.2022.08.005","article-title":"Radiation combined with KRAS-MEK inhibitors enhances anticancer immunity in KRAS-mutated tumor models","volume":"252","author":"Zheng","year":"2023","journal-title":"Transl. Res."},{"issue":"3-4","key":"10.1016\/j.critrevonc.2026.105516_bib302","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08830180902978120","article-title":"Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation","volume":"28","author":"Zhou","year":"2009","journal-title":"Int. Rev. Immunol."},{"issue":"6494","key":"10.1016\/j.critrevonc.2026.105516_bib303","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz7548","article-title":"Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells","volume":"368","author":"Zhou","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105516_bib304","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12951-025-03288-z","article-title":"MXene-based nanosheet for enhanced glioma therapy via photonic hyperthermia to boost the abscopal effect of radioimmunotherapy","volume":"23","author":"Zhu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105516_bib305","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7150\/ijbs.57445","article-title":"Macrophage contributes to radiation-induced anti-tumor abscopal effect on transplanted breast cancer by HMGB1\/TNF-alpha signaling factors","volume":"17","author":"Zhu","year":"2021","journal-title":"Int. J. Biol. Sci."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:01:41Z","timestamp":1793088101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":305,"alternative-id":["S1040842826004038"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105516","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irradiation-based development of tumor vaccines: Mechanistic insights and translational exploration","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105516"}}